[
    [
        {
            "time": "2020-12-23",
            "original_text": "智飞生物续约默沙东 HPV疫苗独家代理 未来3年或采购超300亿元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "默沙东",
                    "HPV疫苗",
                    "独家代理",
                    "采购金额"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物续约默沙东 HPV疫苗独家代理 未来3年或采购超300亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-23",
            "original_text": "智飞生物：续签默沙东代理协议 未来业绩高增长可期",
            "features": {
                "keywords": [
                    "智飞生物",
                    "默沙东",
                    "代理协议",
                    "业绩增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：续签默沙东代理协议 未来业绩高增长可期",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-23",
            "original_text": "全球新冠疫苗竞速进入下半场：产能大比拼",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "全球竞速",
                    "产能"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "全球新冠疫苗竞速进入下半场：产能大比拼",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-23",
            "original_text": "【行情】生物疫苗板块午后拉升，智飞生物直线拉升涨超2%，未名医药翻红",
            "features": {
                "keywords": [
                    "生物疫苗板块",
                    "智飞生物",
                    "拉升",
                    "涨超2%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【行情】生物疫苗板块午后拉升，智飞生物直线拉升涨超2%，未名医药翻红",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-12-23",
            "original_text": "疫苗板块调整，复星医药、康希诺-U、智飞生物、沃森生物、长春高新普跌",
            "features": {
                "keywords": [
                    "疫苗板块",
                    "复星医药",
                    "康希诺-U",
                    "智飞生物",
                    "普跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗板块调整，复星医药、康希诺-U、智飞生物、沃森生物、长春高新普跌",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-23",
            "original_text": "智飞生物与默沙东签署协议 就疫苗产品基础采购金额进行统一调整",
            "features": {
                "keywords": [
                    "智飞生物",
                    "默沙东",
                    "疫苗产品",
                    "采购金额",
                    "统一调整"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物与默沙东签署协议 就疫苗产品基础采购金额进行统一调整",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]